Passmore AP - Search Results

1

The Vascular Impairment of Cognition Classification Consensus Study.

Skrobot OA, O'Brien J, Black S, Chen C, DeCarli C, Erkinjuntti T, Ford GA, Kalaria RN, Pantoni L, Pasquier F, Roman GC, Wallin A, Sachdev P, Skoog I; VICCCS group; Ben-Shlomo Y, Passmore AP, Love S, Kehoe PG. Skrobot OA, et al. Among authors: passmore ap. Alzheimers Dement. 2017 Jun;13(6):624-633. doi: 10.1016/j.jalz.2016.10.007. Epub 2016 Dec 10. Alzheimers Dement. 2017. PMID: 27960092 Free article.

2

Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.

Passmore AP, Bayer AJ, Steinhagen-Thiessen E. Passmore AP, et al. J Neurol Sci. 2005 Mar 15;229-230:141-6. doi: 10.1016/j.jns.2004.11.017. Epub 2005 Jan 6. J Neurol Sci. 2005. PMID: 15760632

3

The treatment of mild Alzheimer's disease post-NICE.

Connelly PJ, Passmore AP, Lawlor BA. Connelly PJ, et al. Among authors: passmore ap. Int J Geriatr Psychiatry. 2007 Dec;22(12):1262-3. doi: 10.1002/gps.1818. Int J Geriatr Psychiatry. 2007. PMID: 17503543 No abstract available.

4

Elevated platelet beta-secretase activity in mild cognitive impairment.

Liu WW, Todd S, Craig D, Passmore AP, Coulson DT, Murphy S, Irvine GB, Johnston JA. Liu WW, et al. Among authors: passmore ap. Dement Geriatr Cogn Disord. 2007;24(6):464-8. doi: 10.1159/000110739. Epub 2007 Nov 7. Dement Geriatr Cogn Disord. 2007. PMID: 17986817

5

Systematic review: Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia.

McGuinness B, Todd S, Passmore AP, Bullock R. McGuinness B, et al. Among authors: passmore ap. J Neurol Neurosurg Psychiatry. 2008 Jan;79(1):4-5. doi: 10.1136/jnnp.2007.118505. J Neurol Neurosurg Psychiatry. 2008. PMID: 18079296 Review. No abstract available.

6

Inflammation and anti-inflammatory strategies for Alzheimer's disease--a mini-review.

McNaull BB, Todd S, McGuinness B, Passmore AP. McNaull BB, et al. Among authors: passmore ap. Gerontology. 2010;56(1):3-14. doi: 10.1159/000237873. Epub 2009 Sep 10. Gerontology. 2010. PMID: 19752507 Review.

7

Effect of apolipoprotein E and butyrylcholinesterase genotypes on cognitive response to cholinesterase inhibitor treatment at different stages of Alzheimer's disease.

Patterson CE, Todd SA, Passmore AP. Patterson CE, et al. Among authors: passmore ap. Pharmacogenomics J. 2011 Dec;11(6):444-50. doi: 10.1038/tpj.2010.61. Epub 2010 Jul 20. Pharmacogenomics J. 2011. PMID: 20644562

8

Northern Ireland dementia strategy.

Todd S, Wilson D, McGuinness B, Craig D, Passmore AP. Todd S, et al. Among authors: passmore ap. Int J Geriatr Psychiatry. 2010 Sep;25(9):902-4. doi: 10.1002/gps.2594. Int J Geriatr Psychiatry. 2010. PMID: 20803717 No abstract available.

9

Prevention of dementia by ACE inhibitors and angiotensin receptor blockers - potential but not proven.

Todd S, McGuinness B, Passmore AP. Todd S, et al. Among authors: passmore ap. Int J Clin Pract. 2010 Nov;64(12):1595-8. doi: 10.1111/j.1742-1241.2010.02490.x. Int J Clin Pract. 2010. PMID: 20946266 No abstract available.

10

The development of effective biomarkers for Alzheimer's disease: a review.

Henry MS, Passmore AP, Todd S, McGuinness B, Craig D, Johnston JA. Henry MS, et al. Among authors: passmore ap. Int J Geriatr Psychiatry. 2013 Apr;28(4):331-40. doi: 10.1002/gps.3829. Epub 2012 Jun 4. Int J Geriatr Psychiatry. 2013. PMID: 22674539 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters